@HillPharmD I know that journal of clin psychopharm doesn’t have the editor make changes before peer reviewers take a look, although they will have suggestions
@StefanKertesz It would be a missed opportunity to point out that the spike in incarceration rates also coincides with the beginning of the war on drugs
Excited to share a recent pub in @AnnalsofPharm on PHB dosing in #AWS led by @STAPHarmacist and @PElsamadisi! 🚨
💊 Original PHB protocol included a taper based on published studies ⏩ changed to no-taper strategy given expected t1/2
https://t.co/2DXFHBB7dF
I don’t use DOACs in the ICU & I also think that the thromboembolic risk for the few days that the patient will receive phenobarbital is probably small, but the interaction should not be totally dismissed
I just passed peer-review for my first AAPP/NAMI publication 🥲
It’s very small but it’s a consumer tool discussing different harm reduction strategies in people who use drugs! I’ll post the link when it hits the web in January 🎉
I just passed peer-review for my first AAPP/NAMI publication 🥲
It’s very small but it’s a consumer tool discussing different harm reduction strategies in people who use drugs! I’ll post the link when it hits the web in January 🎉
1 🚨Attention please: Turns out #xylazine is a kappa opioid. This validates experience from frontline folks and PWUD. Fresh science from collaborators @nanopharmNC @MadiganLBedard @zenbrainest
Pre-print: https://t.co/13BRYWaUnW
Public health 🧵 below
#TwitteRx#harmreduction
Gave my first psychotropic lecture to a wonderful group of med students yesterday. We discussed neuroleptic and antidepressant meds and the questions I got from them were so engaging!
I don’t know much about AI.
I know it recently passed the US medical licensing exam.
But I also know that talk of it ‘replacing’ doctors is wildly off the mark.
I saw why firsthand tonight on a shift in the ER.
🧵
I’m listening to a NC CME for opioid prescribing. They said “we don’t call them pain meds we call them brain meds bc of what they do to the brain.” “We believe opioids don’t have any place in chronic pain so we don’t ever start them.”